Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Baxter
Queensland Health
US Department of Justice
McKinsey
Healthtrust
Colorcon
McKesson
Harvard Business School

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062644

« Back to Dashboard
NDA 062644 describes CLEOCIN, which is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the CLEOCIN profile page.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-three drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for NDA: 062644

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 062644

Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 062644

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEOCIN
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL 062644 ANDA Pharmacia and Upjohn Company LLC 0009-0760 0009-0760-04 1 BOTTLE in 1 CARTON (0009-0760-04) > 100 mL in 1 BOTTLE
CLEOCIN
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL 062644 ANDA Greenstone LLC 59762-0016 59762-0016-1 1 BOTTLE in 1 CARTON (59762-0016-1) > 100 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 75MG BASE/5ML
Approval Date:Apr 7, 1986TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Healthtrust
US Department of Justice
Deloitte
AstraZeneca
Boehringer Ingelheim
Express Scripts
Fuji
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot